Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
281.8 EUR | +0.45% |
|
+1.17% | +0.16% |
12/06 | BMO Capital Adjusts Price Target on Sherwin-Williams to $360 From $377, Maintains Outperform Rating | MT |
12/06 | BMO Capital Adjusts Price Target on Sherwin-Williams to $360 From $377 | MT |
Strengths
- Analyst opinion has improved significantly over the past four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 28.53 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 3.65 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.16% | 76.41B | - | ||
-15.03% | 33.18B | B- | ||
-14.02% | 30.27B | A- | ||
-7.28% | 15.56B | B | ||
-0.21% | 14.34B | B+ | ||
-22.96% | 10.51B | B+ | ||
+1.85% | 7.63B | B- | ||
-16.93% | 7B | B | ||
+5.87% | 3.34B | B- | ||
-17.58% | 2.85B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SHW Stock
- SJ3 Stock
- Ratings The Sherwin-Williams Company